Surgical staging in endometrial cancer
- 123 Downloads
In several malignancies, it has been demonstrated that the lymph nodal status is the most important pathologic factor affecting prognosis and giving the indication to further adjuvant treatment. The surgical assessment of the lymph nodal status in endometrial cancer is debated since 30 years. Recently, the sentinel lymph node mapping is rapidly gaining clinical acceptance in endometrial cancer. The adoption of Indocyanine Green as a safe and user friendly tracer for sentinel lymph node mapping increased the speed to which this procedure is getting applied in clinical practice. As a consequence of this rapid growth, several fundamental questions have been raised and are still debatable. In this manuscript, we discuss the importance of a known pathological lymph nodal status, the technique of the sentinel lymph node mapping with the reported false negative rates and detection rates according to the different tracers adopted, and the clinical scenarios in which a sentinel lymph node mapping could be employed.
KeywordsEndometrial cancer Laparoscopy Sentinel lymph node mapping Indocyanine green Fluorescence
Compliance with ethical standards
Conflict of interest
The authors declare to have no conflict of interest.
- Buda A, Papadia A, Zapardiel I et al (2016) From conventional radiotracer Tc-99(m) with blue dye to indocyanine green fluorescence: a comparison of methods towards optimization of sentinel lymph node mapping in early stage cervical cancer for a laparoscopic approach. Ann Surg Oncol 23:2959–2965CrossRefGoogle Scholar
- Buda A, Papadia A, Di Martino G et al (2018a) Real-time fluorescent sentinel lymph node mapping with indocyanine green in women with previous conization undergoing laparoscopic surgery for early invasive cervical cancer: comparison with radiotracer ± blue dye. J Minim Invasive Gynecol 25:455–460CrossRefGoogle Scholar
- Buda A, Gasparri ML, Puppo A et al (2018b) Lymph node evaluation in high-risk early stage endometrial cancer: a multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy. Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2018.06.003 Google Scholar
- Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, Gien LT, Urbauer DL, Abu-Rustum NR (2018) Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol 19(10):1394–1403CrossRefGoogle Scholar
- Greene FL, Page DL, Irvin D et al (2003) AJCC cancer staging manual, 6th edn. Springer-Verlag, New York, 223Y240Google Scholar
- Lin H, Ding Z, Kota VG et al (2017) Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Oncotarget 8:46601–46610Google Scholar
- NCCN Clinical Practice Guidelines in Oncology (2018) Uterine neoplasms. Version 1.2018. http://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf
- Papadia A, Zapardiel I, Bussi B, Ghezzi F, Ceccaroni M, De Ponti E, Elisei F, Imboden S, de la Noval BD, Gasparri ML, Di Martino G, De Santiago J, Mueller M, Vecchione F, Dell’Orto F, Buda A (2017d) Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99m with blue dye versus indocyanine green fluorescent dye. J Cancer Res Clin Oncol 143(3):475–480CrossRefGoogle Scholar
- Papadia A, Gasparri ML, Siegenthaler F et al (2017e) FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem? J Cancer Res Clin Oncol 143:491–497CrossRefGoogle Scholar